Turning on an immune pathway in tumors could lead to their destruction
November 3, 2025
MIT researchers show they can use messenger RNA to activate the pathway and trigger the immune system to attack tumors.
MIT researchers show they can use messenger RNA to activate the pathway and trigger the immune system to attack tumors.
Antibody unmasks pancreatic tumors’ ‘sugar-coated’ disguise to keep them from evading immune system
InterVene’s Recana is claimed to be the first fully integrated catheter system to address venous in-stent restenosis (ISR).
Pulsenmore announced today that it received FDA de novo clearance for its home-use prenatal ultrasound platform.
Wandercraft announced today that the FDA expanded the indications for its flagship Atalante X rehabilitation device.
Standard laboratory tests can fail to detect many disease-causing DNA changes. Now, a novel 3D chromosome mapping method can reliably reveal these hidden structural variants and lead to new discoveries.
As chronic liver disease becomes more widespread, researchers at Science Tokyo have developed a lab-grown organoid that replicates a regenerating liver, offering new hope for future treatments.
Now, scientists at the Medical University of Vienna and Imperial College London have developed a new method for precisely detecting the nerve signals remaining after an arm amputation and utilizing them to control an artificial arm.
A research team led by the Institute for Bioengineering of Catalonia (IBEC) and collaborating with the Biomedical Research Institute of A Coruña (INIBIC), as well as other international research groups, has developed pioneering technology that enables human kidney organoids to be produced in a scalable manner.
Imagine a surgeon in the middle of a complex operation, able to get instant biochemical feedback not from a lab down the hall, but from the very tool in their hand. This vision is now one step closer to reality thanks to researchers at the University of Chemistry and Technology, Prague (UCT Prague).